MyMSTeam

There is growing evidence that stem cell therapy — specifically a procedure called autologous hematopoietic stem cell transplantation (AHSCT) — shows real promise for MS. The basic idea is to "reset" the immune system so it stops attacking the nervous system.

Research results have been encouraging:

- A UK study of 271 Show Full Answer

There is growing evidence that stem cell therapy — specifically a procedure called autologous hematopoietic stem cell transplantation (AHSCT) — shows real promise for MS. The basic idea is to "reset" the immune system so it stops attacking the nervous system.

Research results have been encouraging:

- A UK study of 271 people found that 94% had no relapses two years after the procedure
- After four years, 89% remained relapse-free
- A 2024 analysis found it may improve disability scores and reduce brain lesions on MRI However, there are some important things to keep in mind:

- AHSCT is not yet FDA-approved for MS
- Many insurance companies consider it experimental and may not cover costs
- The procedure carries real risks, including serious infection and a small mortality risk (around 2.8%)
- It appears most beneficial for people with relapsing MS who are younger and still mobile
- Those with progressive MS have shown fewer benefits

It seems to work best for people with highly active MS who haven't responded well to other treatments. One major caution — be wary of overseas clinics offering stem cell treatments. MS specialist Dr. Aaron Boster has warned against "stem cell tourism," noting that standards and follow-up care can vary wildly, and outcomes aren't always what's promised.

The safest path is to speak with your neurologist about whether you might be a candidate for a clinical trial studying AHSCT. That's currently the most reliable way to access this therapy.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Study: Nearly 90% Are Relapse-Free 2 Years After Stem Cell Transplant for MS

MS Relapse Rates Drop to Zero Following Stem Cell Transplants — But ‘Risks Are Real,’ Study Says